New pressure-to-cornea index in glaucoma created

Article

A new pressure-to-cornea index (PCI) has been created in an attempt to integrate intraocular pressure (IOP) and central corneal thickness (CCT) into a unified risk factor.

A new pressure-to-cornea index (PCI) has been created in an attempt to integrate intraocular pressure (IOP) and central corneal thickness (CCT) into a unified risk factor, according to a report published in the October issue of the British Journal of Ophthalmology.

Milko Iliev from the University of Bern, Switzerland and colleagues from Ophthalmologists Association Thun, Switzerland and Yale University School of Medicine, New Haven, USA defined PCI as the ration between untreated IOP and CCT3 in mm (ultrasound pachymetry).

PCI was then investigated in 220 normal controls, 53 subjects with normal-tension glaucoma (NTG), 76 with ocular hypertension (OHT) and 89 with primary open-angle glaucoma (POAG). The ability of PCI to discriminate between glaucoma and non-glaucoma was compared with that of three other formulae for correcting IOP for CCT. Receiver operating characteristic curves (ROC) were then built.

The mean PCI value in the control group was 92.0, 129.1 in the NTG group, 134.0 in the OHT group and 173.6 in the POAG group. PCI demonstrated a larger area under the ROC and significantly higher sensitivity at fixed 80% and 90% specificities than any of the other formulae. Optimum PCI cut-off value was 133.8.

The authors believe that PCI may reflect individual susceptibility to a given IOP level and, therefore, represents a glaucoma risk factor.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
© 2025 MJH Life Sciences

All rights reserved.